FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

The FDA granted a supplemental application for ZYTIGA (abiraterone acetate) to update its labeling, expanding or modifying its approved indications for prostate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

SUPPL AP for ZYTIGA (ABIRATERONE ACETATE)